- Filed
- May 27, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 27, 2026 | 6.65M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.45M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$818.64K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $385.54K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $899.78K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $16.23M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $15.16M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $20.47M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $19.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.58M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.6M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $47.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $48.55M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.82 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.84 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.82 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.84 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.37M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $805.56K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $631.38K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $15.83K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.61M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$821.39K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$613.74K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $651.95K |
| Revenue | Q1 2026 · Mar 31, 2026 | $38.21K |